Authors
Seung-Gyun Woo
Published in
Folia microbiologica. Nov 03, 2026. Epub Nov 03, 2026.
Abstract
The increasing prevalence of antibiotic-resistant pathogens and recurrent, biofilm-associated, toxin-mediated, or dysbiosis-related infections has created an urgent need for strategies that complement conventional antibiotics. Broad-spectrum therapy can disrupt commensal microbiota, weaken colonization resistance, and promote opportunistic or recurrent infection. Engineered probiotics offer microbiology-based interventions that can inhibit pathogen growth, disrupt biofilms, attenuate virulence, neutralize toxins, and restore protective microbiota functions. Engineered probiotic and commensal microorganisms can also respond to pathogen- or infection-associated signals, improving therapeutic localization and specificity. This review summarizes strategies for controlling antibiotic-resistant and difficult-to-treat pathogens, including pathogen-responsive antimicrobial production, bacteriocin-, pyocin-, lysin-, and antimicrobial peptide-mediated inhibition, enzymatic biofilm degradation, anti-virulence and toxin-neutralization approaches, restoration of microbiota-mediated colonization resistance, and targeted genetic approaches for pathogen elimination or antibiotic resensitization. Representative systems against Pseudomonas aeruginosa, Clostridioides difficile, Staphylococcus aureus, Listeria monocytogenes, Streptococcus pyogenes, and resistant Enterobacteriaceae are discussed. Major translational challenges include chassis selection, genetic stability, horizontal gene transfer, biocontainment, delivery, manufacturing, regulation, and host-microbiota variability. Engineered probiotics may therefore provide selective, localized, and microbiota-preserving complements to conventional therapy.
PMID:
42975792
Bibliographic data and abstract were imported from PubMed on 04 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0